Candriam SCA’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-408,426
| Closed | -$24.3M | – | 699 |
|
|
2025
Q4 | $24.3M | Sell |
408,426
-134,338
| -25% | -$7.31M | 0.12% | 169 |
|
|
2025
Q3 | $29.4M | Sell |
542,764
-6,891
| -1% | -$394K | 0.15% | 135 |
|
|
2025
Q2 | $30.2M | Sell |
549,655
-58,207
| -10% | -$3.43M | 0.17% | 113 |
|
|
2025
Q1 | $43M | Buy |
607,862
+27,640
| +5% | +$1.86M | 0.27% | 89 |
|
|
2024
Q4 | $38.1M | Buy |
580,222
+252,820
| +77% | +$16.9M | 0.22% | 93 |
|
|
2024
Q3 | $23M | Sell |
327,402
-197,736
| -38% | -$16.5M | 0.13% | 158 |
|
|
2024
Q2 | $43.2M | Buy |
525,138
+146,827
| +39% | +$12.2M | 0.26% | 82 |
|
|
2024
Q1 | $33M | Buy |
378,311
+91,383
| +32% | +$8.18M | 0.21% | 113 |
|
|
2023
Q4 | $27.7M | Sell |
286,928
-61,621
| -18% | -$5.45M | 0.19% | 120 |
|
|
2023
Q3 | $30.8M | Sell |
348,549
-69,478
| -17% | -$6.18M | 0.22% | 98 |
|
|
2023
Q2 | $36.2M | Sell |
418,027
-137,428
| -25% | -$12.9M | 0.26% | 92 |
|
|
2023
Q1 | $49.7M | Buy |
555,455
+54,144
| +11% | +$5.61M | 0.34% | 70 |
|
|
2022
Q4 | $51.9M | Buy |
501,311
+168,416
| +51% | +$15.8M | 0.35% | 68 |
|
|
2022
Q3 | $28.2M | Sell |
332,895
-58,735
| -15% | -$5.23M | 0.2% | 114 |
|
|
2022
Q2 | $32.5M | Sell |
391,630
-21,647
| -5% | -$1.72M | 0.27% | 92 |
|
|
2022
Q1 | $31.9M | Buy |
413,277
+139,070
| +51% | +$11.6M | 0.22% | 107 |
|
|
2021
Q4 | $24.2M | Sell |
274,207
-2,000
| -0.7% | -$165K | 0.15% | 153 |
|
|
2021
Q3 | $21.3M | Buy |
276,207
+168,364
| +156% | +$13.3M | 0.15% | 165 |
|
|
2021
Q2 | $9M | Sell |
107,843
-250,187
| -70% | -$19.8M | 0.06% | 303 |
|
|
2021
Q1 | $30.2M | Hold |
358,030
| – | – | 0.25% | 104 |
|
|
2020
Q4 | $31.4M | Sell |
358,030
-9,789
| -3% | -$776K | 0.25% | 104 |
|
|
2020
Q3 | $28M | Sell |
367,819
-1,821
| -0.5% | -$184K | 0.26% | 92 |
|
|
2020
Q2 | $45.6M | Buy |
369,640
+47,225
| +15% | +$4.69M | 0.48% | 41 |
|
|
2020
Q1 | $26.6M | Hold |
322,415
| – | – | 0.3% | 73 |
|
|
2019
Q4 | $27.3M | Sell |
322,415
-37,105
| -10% | -$2.8M | 0.29% | 73 |
|
|
2019
Q3 | $24.2M | Sell |
359,520
-86,410
| -19% | -$6.66M | 0.32% | 59 |
|
|
2019
Q2 | $38M | Sell |
445,930
-13,922
| -3% | -$1.19M | 0.48% | 38 |
|
|
2019
Q1 | $40.9M | Hold |
459,852
| – | – | 0.52% | 41 |
|
|
2018
Q4 | $39.2M | Buy |
459,852
+55,859
| +14% | +$5.31M | 0.6% | 33 |
|
|
2018
Q3 | $39.2M | Buy |
403,993
+138,700
| +52% | +$13.8M | 0.52% | 34 |
|
|
2018
Q2 | $25M | Buy |
265,293
+55,500
| +26% | +$4.86M | 0.4% | 54 |
|
|
2018
Q1 | $17M | Hold |
209,793
| – | – | 0.29% | 91 |
|
|
2017
Q4 | $18.7M | Sell |
209,793
-23,244
| -10% | -$2.02M | 0.32% | 77 |
|
|
2017
Q3 | $21.7M | Buy |
233,037
+27,937
| +14% | +$2.47M | 0.38% | 68 |
|
|
2017
Q2 | $18.6M | Buy |
205,100
+21,490
| +12% | +$1.96M | 0.35% | 66 |
|
|
2017
Q1 | $16.1M | Sell |
183,610
-4,790
| -3% | -$426K | 0.31% | 78 |
|
|
2016
Q4 | $15.6M | Sell |
188,400
-49,302
| -21% | -$4.24M | 0.36% | 69 |
|
|
2016
Q3 | $22M | Sell |
237,702
-9,398
| -4% | -$885K | 0.53% | 44 |
|
|
2016
Q2 | $19.2M | Buy |
247,100
+38,628
| +19% | +$3.28M | 0.5% | 48 |
|
|
2016
Q1 | $17.1M | Sell |
208,472
-15,807
| -7% | -$1.29M | 0.43% | 60 |
|
|
2015
Q4 | $23.5M | Buy |
224,279
+117
| +0.1% | +$12.2K | 0.63% | 35 |
|
|
2015
Q3 | $23.6M | Buy |
224,162
+10,411
| +5% | +$1.39M | 0.58% | 38 |
|
|
2015
Q2 | $29.2M | Buy |
213,751
+2,976
| +1% | +$369K | 0.61% | 33 |
|
|
2015
Q1 | $26.3M | Buy |
210,775
+27,072
| +15% | +$2.87M | 0.53% | 43 |
|
|
2014
Q4 | $16.6M | Buy |
+183,703
| New | +$15.3M | 0.35% | 85 |
|
Other funds holding BMRN
VCM
VPM